Extensive immunohistochemistry analyses corroborated our findings by showing increased protein levels for GSK-3β and active pGSK-3β-Tyr216 in both HD hippocampal neurons and astrocytes as a function of disease severity. This evidence concerns the gene GSK3B and Huntington disease.